Skip to main content
Premium Trial:

Request an Annual Quote

PositiveID, Receptors Co-Developing Test for Salmonella

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PositiveID and its development partner Receptors today said they will be developing a product for the detection of Salmonella.

The product will be based on Receptors' Combinatorial Artificial Receptor Array, or CARA, technology, which PositiveID said could result in a faster, more efficient sample preparation process. The product may also be extended to other food-borne illnesses, such as E. coli, PositiveID said in a statement.

The CARA technology is based on a limited set of small-molecule building blocks, which are combined to created an array of "receptor environments," according to Receptors' website. The building blocks are covalently immobilized to a support surface, which results "in the reproducible display of all region-, stereo-, and spatial relationships possible for each combination of building blocks without the need for discrete synthesis," the firm said.

The announcement comes as an Iowa company last week issued a recall of about 380 million eggs due to possible Salmonella contamination.

PositiveID, based in Delray Beach, Fla., and Receptors, headquartered in Chaska, Minn., are currently co-developing an in vivo glucose-sensing microchip for diabetes and a point-of-care device for the rapid detection of influenza and other pandemic viruses.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.